239 related articles for article (PubMed ID: 24030353)
21. Inhalatory pentamidine therapy and the duration of the QT interval in HIV-infected patients.
Cardoso JS; Mota-Miranda A; Conde C; Moura B; Rocha-Gonçalves F; Lecour H
Int J Cardiol; 1997 May; 59(3):285-9. PubMed ID: 9183045
[TBL] [Abstract][Full Text] [Related]
22. IV pentamidine for Pneumocystis jiroveci pneumonia prophylaxis in pediatric allogeneic stem cell transplant patients.
Curi DA; Duerst RE; Badke C; Bell J; Chaudhury S; Kletzel M; Schneiderman J; Tse WT; Muller WJ; Hijiya N
Bone Marrow Transplant; 2016 Oct; 51(10):1394-1396. PubMed ID: 27214074
[No Abstract] [Full Text] [Related]
23. Once-a-month administration of intravenous pentamidine to patients infected with human immunodeficiency virus as prophylaxis for Pneumocystis carinii pneumonia.
Ena J; Amador C; Pasquau F; Carbonell C; Benito C; Gutiérrez F; Vilar A
Clin Infect Dis; 1994 Jun; 18(6):901-4. PubMed ID: 8086550
[TBL] [Abstract][Full Text] [Related]
24. Is Aerosolized Pentamidine for Pneumocystis Pneumonia Prophylaxis in Renal Transplant Recipients Not as Safe as We Might Think?
Macesic N; Urbancic K; Ierino F; Grayson ML
Antimicrob Agents Chemother; 2016 Apr; 60(4):2502-4. PubMed ID: 26824946
[TBL] [Abstract][Full Text] [Related]
25. Pneumocystis pneumonia in children receiving chemotherapy.
Prasad P; Nania JJ; Shankar SM
Pediatr Blood Cancer; 2008 Apr; 50(4):896-8. PubMed ID: 17458875
[TBL] [Abstract][Full Text] [Related]
26. Effect of long-term primary aerosolized pentamidine prophylaxis on breakthrough Pneumocystis carinii pneumonia.
Ewig S; Schäfer H; Rockstroh JK; Pickenhain A; Lüderitz B
Eur Respir J; 1996 May; 9(5):1006-12. PubMed ID: 8793464
[TBL] [Abstract][Full Text] [Related]
27. Aerodigestive adverse effects during intravenous pentamidine infusion for Pneumocystis jirovecii pneumonia prophylaxis.
Savaşan S; George A; Sokolowski C; McGraw BJ; Rademacher H
Pediatr Blood Cancer; 2021 Jan; 68(1):e28714. PubMed ID: 32979296
[TBL] [Abstract][Full Text] [Related]
28. Aerosolized pentamidine: a well-tolerated mode of prophylaxis against Pneumocystis carinii pneumonia in older children with human immunodeficiency virus infection.
Orcutt TA; Godwin CR; Pizzo PA; Ognibene FP
Pediatr Infect Dis J; 1992 Apr; 11(4):290-4. PubMed ID: 1565553
[TBL] [Abstract][Full Text] [Related]
29. Torsades de pointes complicating pentamidine therapy of Pneumocystis carinii pneumonia in acute myelogenous leukemia.
Otsuka M; Kanamori H; Sasaki S; Taguchi J; Harano H; Ogawa K; Matsuzaki M; Mohri H; Okubo T; Sumita S; Ochiai H
Intern Med; 1997 Oct; 36(10):705-8. PubMed ID: 9372331
[TBL] [Abstract][Full Text] [Related]
30. Treatment and prophylaxis of Pneumocystis carinii pneumonia.
Castro M
Semin Respir Infect; 1998 Dec; 13(4):296-303. PubMed ID: 9872626
[TBL] [Abstract][Full Text] [Related]
31. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group.
Schneider MM; Hoepelman AI; Eeftinck Schattenkerk JK; Nielsen TL; van der Graaf Y; Frissen JP; van der Ende IM; Kolsters AF; Borleffs JC
N Engl J Med; 1992 Dec; 327(26):1836-41. PubMed ID: 1360145
[TBL] [Abstract][Full Text] [Related]
32. Pneumocystis jirovecii Pneumonia Prophylaxis with Intravenous Pentamidine in Adult Allogeneic Hematopoietic Stem Cell Transplant Patients.
McCollam S; Lewis JS; Bubalo J; Diaz A
Antimicrob Agents Chemother; 2022 Nov; 66(11):e0083322. PubMed ID: 36214573
[TBL] [Abstract][Full Text] [Related]
33. Breakthrough Pneumocystis jiroveci pneumonia under pentamidine prophylaxis: imaging findings revisited.
Pua U
Hong Kong Med J; 2009 Dec; 15(6):490-1. PubMed ID: 19966358
[No Abstract] [Full Text] [Related]
34. Cost and benefit of secondary prophylaxis for Pneumocystis carinii pneumonia.
Castellano AR; Nettleman MD
JAMA; 1991 Aug; 266(6):820-4. PubMed ID: 1907671
[TBL] [Abstract][Full Text] [Related]
35. Successful Pneumocystis carinii pneumonia prophylaxis using aerosolized pentamidine in children with acute leukemia.
Weinthal J; Frost JD; Briones G; Cairo MS
J Clin Oncol; 1994 Jan; 12(1):136-40. PubMed ID: 8270969
[TBL] [Abstract][Full Text] [Related]
36. The use of intravenous pentamidine as prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection.
Schroeder KE; Barton SE
Int J STD AIDS; 1994; 5(5):353-5. PubMed ID: 7819354
[TBL] [Abstract][Full Text] [Related]
37. Pentamidine isethionate in the treatment of Pneumocystis carinii pneumonia.
Drake S; Lampasona V; Nicks HL; Schwarzmann SW
Clin Pharm; 1985; 4(5):507-16. PubMed ID: 3902329
[TBL] [Abstract][Full Text] [Related]
38. Failure of pentamidine as prophylaxis for Pneumocystis carinii pneumonia in HIV-infected children.
Schuval SJ; Bonagura VR
Arch Pediatr Adolesc Med; 1994 Aug; 148(8):876-9. PubMed ID: 8044270
[No Abstract] [Full Text] [Related]
39. Management of Pneumocystis jiroveci pneumonia in children receiving chemotherapy.
Shankar SM; Nania JJ
Paediatr Drugs; 2007; 9(5):301-9. PubMed ID: 17927302
[TBL] [Abstract][Full Text] [Related]
40. [Therapy and prevention of pneumocystis carinii pneumonia].
Goebel FD; Bogner JR
Internist (Berl); 1995 Dec; 36(12):1150-5. PubMed ID: 8567220
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
